Lucia Mazzacurati, Ph.D.
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
biochemistry, geneticsGoogle:
"Lucia Mazzacurati"Mean distance: 17811
Parents
Sign in to add mentor| Robert E. Ferrell | grad student | 2012 | University of Pittsburgh | |
| (Development of a new class of MicroRNA controlled oHSV vectors for treatment of glioblastoma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yochum ZA, Cades J, Mazzacurati L, et al. (2017) A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-driven Lung Cancer. Molecular Cancer Research : McR |
| Mazzacurati L, Lambert QT, Pradhan A, et al. (2015) The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells. Oncotarget |
| Gajula RP, Chettiar ST, Williams RD, et al. (2015) Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells. Neoplasia (New York, N.Y.). 17: 16-31 |
| Mazzacurati L, Marzulli M, Reinhart B, et al. (2015) Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 99-107 |
| Li A, Marzulli M, Mazzacurati L, et al. (2014) Abstract 703: Highly selective HSV virotherapy for glioblastoma Cancer Research. 74: 703-703 |
| Chatley SN, Cades J, Neumann N, et al. (2014) Abstract 4771: Identification of inhibitors of TWIST1 as a treatment for lung cancer Cancer Research. 74: 4771-4771 |
| Mazzacurati L, Chatley SN, Yochum Z, et al. (2014) Abstract 3405: E12 and E47 are essential for TWIST1 dependent suppression of oncogene-induced senescence in NSCLC Cancer Research. 74: 3405-3405 |
| Li A, Marzulli M, Mazzacurati L, et al. (2014) ET-34 * HIGHLY SELECTIVE HSV VIROTHERAPY FOR TREATMENT OF GLIOBLASTOMA Neuro-Oncology. 16: v87-v87 |
| Uchida H, Marzulli M, Nakano K, et al. (2013) Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 561-9 |
| Reinhart B, Mazzacurati L, Forero A, et al. (2012) Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus. Advances in Virology. 2012: 815465 |